MedCity News July 9, 2025
CoraVie Medical CEO Aimee Garza and Dr. Michael Bloch, a hypertension specialist and clinical advisor for the startup, talk about why the healthcare industry needs a better approach to blood pressure monitoring. CoraVie is developing an implantable device that measures patients’ blood pressure, operating in a similar way to continuous glucose monitors. Watch or listen now!
Watch the interview here
Listen to the episode here
Hypertension remains one of the country’s most prevalent yet most uncontrolled conditions, costing the U.S. hundreds of billions of dollars each year. Despite the disease’s widespread presence, the fundamental approach to monitoring patients’ blood pressure hasn’t changed very much over the past century.
CoraVie Medical is seeking to address this problem by offering a...
Today's Sponsors
Today's Sponsor